Bay Rivers Group - SINGULAR GENOMICS SYSTEMS IN ownership

SINGULAR GENOMICS SYSTEMS IN's ticker is OMIC and the CUSIP is 82933R100. A total of 77 filers reported holding SINGULAR GENOMICS SYSTEMS IN in Q2 2022. The put-call ratio across all filers is - and the average weighting 1.1%.

Quarter-by-quarter ownership
Bay Rivers Group ownership history of SINGULAR GENOMICS SYSTEMS IN
ValueSharesWeighting
Q3 2023$5,334
-54.1%
14,0000.0%0.00%
-55.6%
Q2 2023$11,620
-31.4%
14,0000.0%0.01%
-40.0%
Q1 2023$16,940
-39.8%
14,0000.0%0.02%
-46.4%
Q4 2022$28,140
-19.6%
14,0000.0%0.03%
-20.0%
Q3 2022$35,000
-34.0%
14,0000.0%0.04%
-25.5%
Q2 2022$53,00014,0000.05%
Other shareholders
SINGULAR GENOMICS SYSTEMS IN shareholders Q2 2022
NameSharesValueWeighting ↓
ARCH Venture Management, LLC 3,798,926$7,635,8411.96%
Tikvah Management LLC 316,854$636,8770.30%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 6,450,871$12,966,2510.27%
Triatomic Management LP 155,411$312,3760.26%
Casdin Capital, LLC 1,345,722$2,704,9010.21%
Perceptive Advisors 3,282,275$6,597,3730.18%
Oasis Management Co Ltd. 221,729$445,6750.09%
PLATINUM INVESTMENT MANAGEMENT LTD 881,068$1,770,9470.07%
Anson Funds Management LP 169,747$341,1910.06%
Weil Company, Inc. 53,202$106,9360.05%
View complete list of SINGULAR GENOMICS SYSTEMS IN shareholders